{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T04:03:18Z","timestamp":1789704198978,"version":"4.0.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T00:00:00Z","timestamp":1769817600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T00:00:00Z","timestamp":1769817600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Gene Ther"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1038\/s41417-026-01002-1","type":"journal-article","created":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T12:03:08Z","timestamp":1769860988000},"page":"645-655","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["C1orf35 contributes to high anabolic metabolism by simultaneously promoting aerobic glycolysis and oxidative phosphorylation in multiple myeloma cells"],"prefix":"10.1038","volume":"33","author":[{"given":"Rui","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saiqun","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruoyan","family":"Dang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Xin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5548-1241","authenticated-orcid":false,"given":"Jingping","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,31]]},"reference":[{"key":"1002_CR1","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan D. Hallmarks of cancer: new dimensions. Cancer Discov. 2022;12:31\u201346.","journal-title":"Cancer Discov"},{"key":"1002_CR2","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41573-021-00339-6","volume":"21","author":"ZE Stine","year":"2022","unstructured":"Stine ZE, Schug ZT, Salvino JM, Dang CV. Targeting cancer metabolism in the era of precision oncology. Nat Rev Drug Discov. 2022;21:141\u201362.","journal-title":"Nat Rev Drug Discov"},{"key":"1002_CR3","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1038\/s42255-023-00927-3","volume":"5","author":"CB Thompson","year":"2023","unstructured":"Thompson CB, Vousden KH, Johnson RS, Koppenol WH, Sies H, Lu Z, et al. A century of the Warburg effect. Nat Metab. 2023;5:1840\u20133.","journal-title":"Nat Metab"},{"key":"1002_CR4","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1126\/science.1160809","volume":"324","author":"MG Vander Heiden","year":"2009","unstructured":"Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science. 2009;324:1029\u201333.","journal-title":"Science"},{"key":"1002_CR5","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nrc3038","volume":"11","author":"WH Koppenol","year":"2011","unstructured":"Koppenol WH, Bounds PL, Dang CV. Otto Warburg\u2019s contributions to current concepts of cancer metabolism. Nat Rev Cancer. 2011;11:325\u201337.","journal-title":"Nat Rev Cancer"},{"key":"1002_CR6","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1126\/science.124.3215.267","volume":"124","author":"S Weinhouse","year":"1956","unstructured":"Weinhouse S. On respiratory impairment in cancer cells. Science. 1956;124:267\u20139.","journal-title":"Science"},{"key":"1002_CR7","first-page":"2007","volume":"32","author":"S Weinhouse","year":"1972","unstructured":"Weinhouse S. Glycolysis, respiration, and anomalous gene expression in experimental hepatomas: G.H.A. Clowes memorial lecture. Cancer Res. 1972;32:2007\u201316.","journal-title":"Cancer Res"},{"key":"1002_CR8","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/nrc.2016.77","volume":"16","author":"N Hay","year":"2016","unstructured":"Hay N. Reprogramming glucose metabolism in cancer: can it be exploited for cancer therapy? Nat Rev Cancer. 2016;16:635\u201349.","journal-title":"Nat Rev Cancer"},{"key":"1002_CR9","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1016\/j.ccell.2019.03.007","volume":"35","author":"M Elgendy","year":"2019","unstructured":"Elgendy M, Ciro M, Hosseini A, Weiszmann J, Mazzarella L, Ferrari E, et al. Combination of Hypoglycemia and Metformin Impairs Tumor Metabolic Plasticity and Growth by Modulating the PP2A-GSK3beta-MCL-1 Axis. Cancer Cell. 2019;35:798\u2013815.e5.","journal-title":"Cancer Cell"},{"key":"1002_CR10","doi-asserted-by":"publisher","first-page":"5907","DOI":"10.1158\/0008-5472.CAN-19-1789","volume":"79","author":"S Xu","year":"2019","unstructured":"Xu S, Herschman HR. A tumor agnostic therapeutic strategy for hexokinase 1-null\/hexokinase 2-positive cancers. Cancer Res. 2019;79:5907\u201314.","journal-title":"Cancer Res"},{"key":"1002_CR11","first-page":"143","volume":"35","author":"JY Tian","year":"2003","unstructured":"Tian JY, Hu WX, Tian EM, Shi YW, Shen QX, Tang LJ, et al. Cloning and sequence analysis of tumor-associated gene hMMTAG2 from human multiple myeloma cell line ARH-77. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai). 2003;35:143\u20138.","journal-title":"Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai)"},{"key":"1002_CR12","doi-asserted-by":"publisher","first-page":"3354","DOI":"10.1038\/s41388-020-1222-7","volume":"39","author":"SQ Luo","year":"2020","unstructured":"Luo SQ, Xiong DH, Li J, Li G, Wang Y, Zhang JM, et al. C1orf35 contributes to tumorigenesis by activating c-MYC transcription in multiple myeloma. Oncogene. 2020;39:3354\u201366.","journal-title":"Oncogene"},{"key":"1002_CR13","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1097\/HJH.0000000000002023","volume":"37","author":"PE Melton","year":"2019","unstructured":"Melton PE, Johnson MP, Gokhale-Agashe D, Rea AJ, Ariff A, Cadby G, et al. Whole-exome sequencing in multiplex preeclampsia families identifies novel candidate susceptibility genes. J Hypertens. 2019;37:997\u20131011.","journal-title":"J Hypertens"},{"key":"1002_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s12920-021-00883-5","volume":"14","author":"T Meier","year":"2021","unstructured":"Meier T, Timm M, Montani M, Wilkens L. Gene networks and transcriptional regulators associated with liver cancer development and progression. BMC Med Genomics. 2021;14:41.","journal-title":"BMC Med Genomics"},{"key":"1002_CR15","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1042\/BST0371385","volume":"37","author":"DG Nicholls","year":"2009","unstructured":"Nicholls DG. Spare respiratory capacity, oxidative stress and excitotoxicity. Biochem Soc Trans. 2009;37:1385\u20138.","journal-title":"Biochem Soc Trans"},{"key":"1002_CR16","doi-asserted-by":"publisher","first-page":"24760","DOI":"10.1074\/jbc.M115.668707","volume":"290","author":"AD James","year":"2015","unstructured":"James AD, Patel W, Butt Z, Adiamah M, Dakhel R, Latif A, et al. The plasma membrane calcium pump in pancreatic cancer cells exhibiting the Warburg effect relies on glycolytic ATP. J Biol Chem. 2015;290:24760\u201371.","journal-title":"J Biol Chem"},{"key":"1002_CR17","doi-asserted-by":"publisher","first-page":"6479","DOI":"10.1158\/1078-0432.CCR-09-0889","volume":"15","author":"CV Dang","year":"2009","unstructured":"Dang CV, Le A, Gao P. MYC-induced cancer cell energy metabolism and therapeutic opportunities. Clin Cancer Res. 2009;15:6479\u201383.","journal-title":"Clin Cancer Res"},{"key":"1002_CR18","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13045-017-0392-4","volume":"10","author":"Z Gu","year":"2017","unstructured":"Gu Z, Xia J, Xu H, Frech I, Tricot G, Zhan F. NEK2 promotes aerobic glycolysis in multiple myeloma through regulating splicing of pyruvate kinase. J Hematol Oncol. 2017;10:17.","journal-title":"J Hematol Oncol"},{"key":"1002_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.136820","volume":"282","author":"Y Ge","year":"2024","unstructured":"Ge Y, Janson V, Liu H. Comprehensive review on leucine-rich pentatricopeptide repeat-containing protein (LRPPRC, PPR protein): a burgeoning target for cancer therapy. Int J Biol Macromol. 2024;282:136820.","journal-title":"Int J Biol Macromol"},{"key":"1002_CR20","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.molcel.2012.05.021","volume":"46","author":"AG Baltz","year":"2012","unstructured":"Baltz AG, Munschauer M, Schwanhausser B, Vasile A, Murakawa Y, Schueler M, et al. The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. Mol Cell. 2012;46:674\u201390.","journal-title":"Mol Cell"},{"key":"1002_CR21","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1016\/j.cell.2012.04.031","volume":"149","author":"A Castello","year":"2012","unstructured":"Castello A, Fischer B, Eichelbaum K, Horos R, Beckmann BM, Strein C, et al. Insights into RNA biology from an atlas of mammalian mRNA-binding proteins. Cell. 2012;149:1393\u2013406.","journal-title":"Cell"},{"key":"1002_CR22","doi-asserted-by":"publisher","first-page":"2580","DOI":"10.1093\/hmg\/ddt652","volume":"23","author":"A Mourier","year":"2014","unstructured":"Mourier A, Ruzzenente B, Brandt T, Kuhlbrandt W, Larsson NG. Loss of LRPPRC causes ATP synthase deficiency. Hum Mol Genet. 2014;23:2580\u201392.","journal-title":"Hum Mol Genet"},{"key":"1002_CR23","doi-asserted-by":"publisher","first-page":"3186","DOI":"10.1093\/hmg\/ddx202","volume":"26","author":"A Cuillerier","year":"2017","unstructured":"Cuillerier A, Honarmand S, Cadete VJJ, Ruiz M, Forest A, Deschenes S, et al. Loss of hepatic LRPPRC alters mitochondrial bioenergetics, regulation of permeability transition and trans-membrane ROS diffusion. Hum Mol Genet. 2017;26:3186\u2013201.","journal-title":"Hum Mol Genet"},{"key":"1002_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-39854-y","volume":"14","author":"W Zhou","year":"2023","unstructured":"Zhou W, Wang W, Liang Y, Jiang R, Qiu F, Shao X, et al. The RNA-binding protein LRPPRC promotes resistance to CDK4\/6 inhibition in lung cancer. Nat Commun. 2023;14:4212.","journal-title":"Nat Commun"},{"key":"1002_CR25","doi-asserted-by":"publisher","first-page":"6340","DOI":"10.1093\/nar\/gkaa335","volume":"48","author":"SM Bong","year":"2020","unstructured":"Bong SM, Bae SH, Song B, Gwak H, Yang SW, Kim S, et al. Regulation of mRNA export through API5 and nuclear FGF2 interaction. Nucleic Acids Res. 2020;48:6340\u201352.","journal-title":"Nucleic Acids Res"},{"key":"1002_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-04238-x","volume":"12","author":"JY Liu","year":"2021","unstructured":"Liu JY, Chen YJ, Feng HH, Chen ZL, Wang YL, Yang JE, et al. LncRNA SNHG17 interacts with LRPPRC to stabilize c-Myc protein and promote G1\/S transition and cell proliferation. Cell Death Dis. 2021;12:970.","journal-title":"Cell Death Dis"},{"key":"1002_CR27","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1583","volume":"14","author":"Y Yu","year":"2024","unstructured":"Yu Y, Deng H, Wang W, Xiao S, Zheng R, Lv L, et al. LRPPRC promotes glycolysis by stabilising LDHA mRNA and its knockdown plus glutamine inhibitor induces synthetic lethality via m(6) A modification in triple-negative breast cancer. Clin Transl Med. 2024;14:e1583.","journal-title":"Clin Transl Med"},{"key":"1002_CR28","doi-asserted-by":"publisher","first-page":"18492","DOI":"10.1021\/jacs.9b08777","volume":"141","author":"W Zhou","year":"2019","unstructured":"Zhou W, Sun G, Zhang Z, Zhao L, Xu L, Yuan H, et al. Proteasome-Independent Protein Knockdown by Small-Molecule Inhibitor for the Undruggable Lung Adenocarcinoma. J Am Chem Soc. 2019;141:18492\u20139.","journal-title":"J Am Chem Soc"},{"key":"1002_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.131966","volume":"269","author":"H Liu","year":"2024","unstructured":"Liu H, Zhou Y, Fredimoses M, Niu P, Ge Y, Wu R, et al. Targeting leucine-rich PPR motif-containing protein\/LRPPRC by 5,7,4\u2019-trimethoxyflavone suppresses esophageal squamous cell carcinoma progression. Int J Biol Macromol. 2024;269:131966.","journal-title":"Int J Biol Macromol"},{"key":"1002_CR30","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1038\/s41568-018-0074-8","volume":"18","author":"D Mossmann","year":"2018","unstructured":"Mossmann D, Park S, Hall MN. mTOR signalling and cellular metabolism are mutual determinants in cancer. Nat Rev Cancer. 2018;18:744\u201357.","journal-title":"Nat Rev Cancer"},{"key":"1002_CR31","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1038\/s41580-022-00506-6","volume":"23","author":"CF Bennett","year":"2022","unstructured":"Bennett CF, Latorre-Muro P, Puigserver P. Mechanisms of mitochondrial respiratory adaptation. Nat Rev Mol Cell Biol. 2022;23:817\u201335.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1002_CR32","doi-asserted-by":"publisher","first-page":"C58","DOI":"10.1152\/ajpcell.00160.2017","volume":"317","author":"Y Mukaneza","year":"2019","unstructured":"Mukaneza Y, Cohen A, Rivard ME, Tardif J, Deschenes S, Ruiz M, et al. mTORC1 is required for expression of LRPPRC and cytochrome-c oxidase but not HIF-1alpha in Leigh syndrome French Canadian type patient fibroblasts. Am J Physiol Cell Physiol. 2019;317:C58\u201367.","journal-title":"Am J Physiol Cell Physiol"},{"key":"1002_CR33","doi-asserted-by":"publisher","first-page":"3999","DOI":"10.1038\/onc.2011.576","volume":"31","author":"LM Ferreira","year":"2012","unstructured":"Ferreira LM, Hebrant A, Dumont JE. Metabolic reprogramming of the tumor. Oncogene. 2012;31:3999\u20134011.","journal-title":"Oncogene"},{"key":"1002_CR34","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.bbabio.2010.10.012","volume":"1807","author":"C Jose","year":"2011","unstructured":"Jose C, Bellance N, Rossignol R. Choosing between glycolysis and oxidative phosphorylation: a tumor\u2019s dilemma? Biochim Biophys Acta. 2011;1807:552\u201361.","journal-title":"Biochim Biophys Acta"},{"key":"1002_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01221-z","volume":"8","author":"SJ Siira","year":"2017","unstructured":"Siira SJ, Spahr H, Shearwood AJ, Ruzzenente B, Larsson NG, Rackham O, et al. LRPPRC-mediated folding of the mitochondrial transcriptome. Nat Commun. 2017;8:1532.","journal-title":"Nat Commun"},{"key":"1002_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.neo.2024.100974","volume":"50","author":"X Zhou","year":"2024","unstructured":"Zhou X, He R, Hu WX, Luo S, Hu J. Targeting myeloma metabolism: How abnormal metabolism contributes to multiple myeloma progression and resistance to proteasome inhibitors. Neoplasia. 2024;50:100974.","journal-title":"Neoplasia"}],"container-title":["Cancer Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41417-026-01002-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41417-026-01002-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41417-026-01002-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T05:35:38Z","timestamp":1783920938000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41417-026-01002-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,31]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["1002"],"URL":"https:\/\/doi.org\/10.1038\/s41417-026-01002-1","relation":{},"ISSN":["0929-1903","1476-5500"],"issn-type":[{"value":"0929-1903","type":"print"},{"value":"1476-5500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,31]]},"assertion":[{"value":"12 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This article does not contain any studies with human participants performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}